BIOMAT Database Logo BIOMAT Database Logo

The interaction of some N-phenylanthranilic acid derivatives with cyclodextrins in phosphate buffers. 1976

M Otagiri, and J H Perrin, and K Uekama, and K Ikeda, and K Takeo

UI MeSH Term Description Entries
D010710 Phosphates Inorganic salts of phosphoric acid. Inorganic Phosphate,Phosphates, Inorganic,Inorganic Phosphates,Orthophosphate,Phosphate,Phosphate, Inorganic
D011134 Polysaccharides Long chain polymeric CARBOHYDRATES composed of MONOSACCHARIDES linked by glycosidic bonds. Glycan,Glycans,Polysaccharide
D002021 Buffers A chemical system that functions to control the levels of specific ions in solution. When the level of hydrogen ion in solution is controlled the system is called a pH buffer. Buffer
D002626 Chemistry, Pharmaceutical Chemistry dealing with the composition and preparation of agents having PHARMACOLOGIC ACTIONS or diagnostic use. Medicinal Chemistry,Chemistry, Pharmaceutic,Pharmaceutic Chemistry,Pharmaceutical Chemistry,Chemistry, Medicinal
D003912 Dextrins A group of low-molecular-weight carbohydrates produced by the hydrolysis of STARCH or GLYCOGEN. They are mixtures of polymers of D-glucose units linked by alpha-(1->4) or alpha-(1->6) glycosidic bonds. Dextrin
D062367 ortho-Aminobenzoates Benzoic acids, salts, or esters that contain an amino group attached to carbon number 2 or 6 of the benzene ring structure. 2-Aminobenzoates,6-Aminobenzoates,Anthranilates,Anthranilic Acids,o-Aminobenzoates,o-Aminobenzoic Acids,ortho-Aminobenzoic Acids,6 Aminobenzoates,Acids, Anthranilic,Acids, o-Aminobenzoic,Acids, ortho-Aminobenzoic,o Aminobenzoates,o Aminobenzoic Acids,ortho Aminobenzoates,ortho Aminobenzoic Acids

Related Publications

M Otagiri, and J H Perrin, and K Uekama, and K Ikeda, and K Takeo
Binding of N-phenylanthranilic acid derivatives to bovine serum albumin.
October 1982, The Journal of pharmacy and pharmacology,
M Otagiri, and J H Perrin, and K Uekama, and K Ikeda, and K Takeo
[Relationship between the structure of N-phenylanthranilic acid derivatives and their antiphlogistic activity. I].
July 1973, Acta pharmaceutica Hungarica,
M Otagiri, and J H Perrin, and K Uekama, and K Ikeda, and K Takeo
[Relationship between the structure of N-phenylanthranilic acid derivatives and their antiphlogistic action. II].
July 1973, Acta pharmaceutica Hungarica,
M Otagiri, and J H Perrin, and K Uekama, and K Ikeda, and K Takeo
Inhibition of strigolactone receptors by N-phenylanthranilic acid derivatives: Structural and functional insights.
April 2018, The Journal of biological chemistry,
M Otagiri, and J H Perrin, and K Uekama, and K Ikeda, and K Takeo
Some observations on the redox behaviour of N-phenylanthranilic acid indicator in iron(II) titrations.
April 1973, Talanta,
M Otagiri, and J H Perrin, and K Uekama, and K Ikeda, and K Takeo
Anti-inflammatory properties of N-phenylanthranilic acid derivatives in relation to uncoupling of oxidative phosphorylation.
April 1972, Japanese journal of pharmacology,
M Otagiri, and J H Perrin, and K Uekama, and K Ikeda, and K Takeo
Second-order calibration of excitation-emission matrix fluorescence spectra for the determination of N-phenylanthranilic acid derivatives.
March 2006, Applied spectroscopy,
M Otagiri, and J H Perrin, and K Uekama, and K Ikeda, and K Takeo
Native fluorescence of analgesics derived from N-phenylanthranilic acid.
July 1973, Talanta,
M Otagiri, and J H Perrin, and K Uekama, and K Ikeda, and K Takeo
The kinetics of papillotoxic doses of 3H-N-phenylanthranilic acid in rats.
January 1989, Renal physiology and biochemistry,
M Otagiri, and J H Perrin, and K Uekama, and K Ikeda, and K Takeo
MRI histopathology correlation of N-phenylanthranilic acid induced nephropathy in rats.
December 2006, The British journal of radiology,
Copied contents to your clipboard!